RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Rochester, MN · +17 more sites
3 recruiting lupus studies with a site in Rochester, MN.
Sponsor: Amgen
Rochester, MN · +17 more sites
Sponsor: AstraZeneca
Rochester, MN · +14 more sites
Sponsor: Regeneron Pharmaceuticals
Rochester, MN · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.